HG
Hideki Garren
Chief Medical Officer

Hideki Garren insider trades: Prothena Corp Public (PRTA) stock sales

Chief Medical Officer, Prothena Corp Public Last trade Sep 13, 2023 18 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2022
2
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Hideki reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 13, 2023PRTA↓ Sell$111K
Aug 16, 2023PRTA↓ Sell$117K
Jul 12, 2023PRTA↓ Sell$135K
Jun 16, 2023PRTA↓ Sell$542K
Jun 14, 2023PRTA↓ Sell$347K
Mar 15, 2023PRTA↓ Sell$581K
Dec 1, 2022PRTA↓ Sell$250K
Nov 1, 2022PRTA↓ Sell$248K
Oct 3, 2022PRTA↓ Sell$244K
Sep 15, 2022PRTA↓ Sell$120K
Aug 1, 2022PRTA↓ Sell$122K
Jul 6, 2022PRTA↓ Sell$240K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other PRTA insiders

Open-market trades in the last 12 months

About Hideki Garren's insider trades

Hideki Garren is Chief Medical Officer at Prothena Corp Public (PRTA). Since Jul 6, 2022, Hideki has reported no open-market purchases and 12 sales worth $3.1M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (12 filings), grants and awards (5 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PRTA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.